A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment

Completed · Phase 1

Conditions studied: Hepatic Insufficiency

In brief

The purpose of this study is to measure how much of the drug gets into the bloodstream and how long it takes the body to remove it when given to participants with hepatic (liver) impairment compared to participants with normal hepatic function. Information about any side effects that may occur will also be collected. This study will last approximately 28 days, not including screening.

Key facts

Study ID

NCT01836185

Run by

Eli Lilly and Company

People needed

32

Starts

2013-04-01

Expected to finish

2013-10-01

Last updated by the study team

2018-10-12

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants have given written informed consent approved by the ethical review board (ERB) governing the site
• Female participants should be of non-childbearing potential
• Have a body mass index (BMI) of 18 to 40 kilograms per square meter (kg/m\^2)
• Healthy participants have normal hepatic function as determined by medical history, physical examination, and other screening procedures
• Individuals with hepatic impairment classified as Child-Pugh score A, B, or C (mild, moderate, or severe impairment)

You may not qualify if…

• Has had esophagus variceal bleeding within 3 months of check-in
• Have the need to take medications that may interfere with how the liver removes the drug
• Have evidence of cancer in the liver
• Consumes excessively large amounts of drinks with caffeine or alcohol

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Miami, Florida, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.